Cargando...
Androgen receptor targeted therapies in castration‐resistant prostate cancer: Bench to clinic
The androgen receptor is a transcription factor and validated therapeutic target for prostate cancer. Androgen deprivation therapy remains the gold standard treatment, but it is not curative, and eventually the disease will return as lethal castration‐resistant prostate cancer. There have been impro...
Gardado en:
| Publicado en: | Int J Urol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6680212/ https://ncbi.nlm.nih.gov/pubmed/27302572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/iju.13137 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|